GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Medicines Corp Ltd (SHSE:600511) » Definitions » Other Income (Expense)

China National Medicines (SHSE:600511) Other Income (Expense) : ¥353 Mil (TTM As of Mar. 2024)


View and export this data going back to 2002. Start your Free Trial

What is China National Medicines Other Income (Expense)?

China National Medicines's other income expense for the China National Medicines's pretax income for the three months ended in Mar. 2024 was ¥72 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥353 Mil.

China National Medicines Other Income (Expense) Historical Data

The historical data trend for China National Medicines's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Medicines Other Income (Expense) Chart

China National Medicines Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 83.86 208.73 232.92 255.68 348.16

China National Medicines Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.67 115.86 61.58 104.06 71.74

China National Medicines Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥353 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China National Medicines  (SHSE:600511) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

China National Medicines (SHSE:600511) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Medicines Corp Ltd (SHSE:600511) » Definitions » Other Income (Expense)
Comparable Companies
SZSE:000028 SHSE:600056 SHSE:600739 SZSE:000950 SHSE:603368 SZSE:002589 SZSE:002551 SHSE:601607 MCK COR CAH HSIC HKSE:01099 MIL:AMP NZSE:EBO XSWX:GALE TSE:7459 TSE:2784 PDCO TSE:9987
Traded in Other Exchanges
N/A
Address
No. 12 A, Sanyuan West Lane, Yongwai, Chongwen District, Beijing, CHN, 100077
Website
http://www.cncm.com.cn
China National Medicines Corp Ltd focuses on producing special drugs and high-end prescription drugs. Its main goal is to provide customers with professional medical services. The company is also engaged in proprietary Chinese medicines, Chinese medicine decoction pieces, Chinese medicinal materials, chemical preparations, chemical raw materials, antibiotics, and biochemical drugs.

China National Medicines (SHSE:600511) Headlines

No Headlines